Eli Lilly and Company, currently buoyed by the explosive success of its GLP-1 franchise, has announced its intent to acquire…
Read More
EClinical Solutions study models 241% ROI from AI-powered clinical trial data platform
The pharmaceutical industry, perpetually challenged by the immense costs, protracted timelines, and inherent complexities of bringing new therapies to market,…
Read More
SLAS Europe 2026 Set to Unveil Transformative Innovations in Drug Discovery and Laboratory Automation in Vienna
The Society for Laboratory Automation and Screening (SLAS) 2026 European Conference and Exhibition is poised to converge in Vienna, Austria,…
Read More
Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion
The majority of these high-value collaborations, roughly half, involved firms of U.S. origin, predominantly structured as mergers and acquisitions (M&A).…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
In recent years, the landscape of drug safety testing has undergone a profound transformation, marked by the rapid acceleration of…
Read More
BioNTech’s Dramatic Pivot: From Pandemic Powerhouse to Oncology Challenger Amidst Job Cuts and Shifting Fortunes
The German biotechnology firm BioNTech, once a beacon of innovation and a financial titan thanks to its pioneering mRNA COVID-19…
Read More
Robotic Phlebotomy Study Signals Automation Shift for Clinical Labs
The landscape of clinical diagnostics is on the cusp of a significant transformation, as a recently published multicenter clinical study…
Read More
Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.
The pharmaceutical industry, emerging from a period characterized by uneven growth and significant challenges in research and development (R&D) productivity,…
Read More
Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Novo Nordisk Patent Lapse, Paving Way for Enhanced Access and Affordability
In a landmark decision poised to significantly reshape the pharmaceutical landscape for diabetes and obesity management, Health Canada has granted…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read MoreYOU MAY HAVE MISSED
